Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
PHARMACOR CINACALCET, AKM CINACALCET (Pharmacor Pty Ltd)
Product name
PHARMACOR CINACALCET, AKM CINACALCET
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
221 working days (255)
Active ingredients
cinacalcet hydrochloride
Registration type
New generic medicine
Indication
PHARMACOR CINACALCET, AKM CINACALCET (film-coated tablets) may be used to treat the biochemical manifestations of secondary hyperparathyroidism in patients with end stage renal disease, receiving dialysis. PHARMACOR CINACALCET, AKM CINACALCET should be used as adjunctive therapy.
PHARMACOR CINACALCET, AKM CINACALCET is also indicated for the treatment of hypercalcaemia in patients with parathyroid carcinoma.
PHARMACOR CINACALCET, AKM CINACALCET may also be used to treat the biochemical manifestations of primary hyperparathyroidism in patients for whom parathyroidectomy is not a treatment option.